Type 2 diabetes. Endocrine, Nutritional and metabolic diseases
Conditions
Interventions
Intervention 1: Placebo group will receive 10 gram of maltodextrin powder in the form of 5 gram packs with breakfast and dinner meals for 8 weeks. The supplement will be given monthly and during the
Placebo
Treatment - Drugs
Placebo group will receive 10 gram of maltodextrin powder in the form of 5 gram packs with breakfast and dinner meals for 8 weeks. The supplement will be given monthly and during the consumption pos
Resistant dextrin group will receive 10 gram of Resistant dextrin powder in the form of 5 gram packs with breakfast and dinner meals for 8 weeks. The supplement will be given monthly and during the
Sponsors
Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age 30-50 years old; 25= BMI <35; having diabetes at least 6 months prior to the study; consumption of blood glucose lowering drug; ?ber intake <25 g ?ber/day. Exclusion criteria: Consumption of antioxidants supplements during last 3 months; using insulin, pregnancy; lactation; acute renal disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IL4. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA.;IL12. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA.;LPS. Timepoint: Before and after 8 weeks of intervention. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| BMI. Timepoint: At baseline and after 8 weeks of intervention. Method of measurement: Weight divided by Height Square. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParvin Dehghan
Tabriz University Of Medical Sciences
Outcome results
None listed